Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?

[1]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[2]  R. Mason,et al.  Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model , 2015, Journal of magnetic resonance imaging : JMRI.

[3]  Xiaohan Liu,et al.  Comparison of stretched‐Exponential and monoexponential model diffusion‐Weighted imaging in prostate cancer and normal tissues , 2015, Journal of magnetic resonance imaging : JMRI.

[4]  Haoyan Zhou,et al.  Ultrasound imaging beyond the vasculature with new generation contrast agents. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[5]  E. Demirci,et al.  Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging , 2015, Nuclear medicine communications.

[6]  Bhushan L. Thakur,et al.  Molecular Imaging of Therapeutic Potential of Reporter Probes. , 2015, Current drug targets.

[7]  Hairong Zheng,et al.  A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging. , 2015, Contrast media & molecular imaging.

[8]  Zhiqiang Zhang,et al.  Comparison of Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging and Arterial Spin Labeling MR Imaging in Gliomas , 2015, BioMed research international.

[9]  L. Rich,et al.  Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level-dependent MR imaging. , 2015, Radiology.

[10]  David A Gutman,et al.  Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death. , 2015, Radiology.

[11]  Kai Chen,et al.  Development of PET probes for cancer imaging. , 2015, Current topics in medicinal chemistry.

[12]  J. Bulte,et al.  Molecular engineering of nonmetallic biosensors for CEST MRI. , 2015, ACS chemical biology.

[13]  A. Pupi,et al.  Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis. , 2015, Bioorganic & medicinal chemistry.

[14]  P. Lambin,et al.  Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles. , 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[15]  N. Dowson,et al.  PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma. , 2015, Drug discovery today.

[16]  U. Haberkorn,et al.  Cancer Stratification by Molecular Imaging , 2015, International journal of molecular sciences.

[17]  Catherine Coolens,et al.  Multimodality Functional Imaging in Radiation Therapy Planning: Relationships between Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and 18F-FDG PET , 2015, Comput. Math. Methods Medicine.

[18]  Rivka R Colen,et al.  Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology. , 2015, Neuroimaging clinics of North America.

[19]  W. Pope.  Genomics of brain tumor imaging. , 2015, Neuroimaging clinics of North America.

[20]  Andrew H. Beck,et al.  Noninvasive imaging of tumor burden and molecular pathways in mouse models of cancer. , 2015, Cold Spring Harbor protocols.

[21]  Baorui Liu,et al.  Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo , 2015, Nature Communications.

[22]  C. Ulrich,et al.  Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally , 2014, Journal of the National Cancer Institute.

[23]  F J Gilbert,et al.  Imaging tumour hypoxia with positron emission tomography , 2014, British Journal of Cancer.

[24]  Pan Li,et al.  Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. , 2015, Biomaterials.

[25]  Y. Tsushima,et al.  In vivo molecular imaging of cancer stem cells. , 2015, American journal of nuclear medicine and molecular imaging.

[26]  Summer L. Gibbs,et al.  Molecular Imaging: From Bench to Clinic , 2014, BioMed research international.

[27]  David J. Yang,et al.  Advances in Molecular Pathway-Directed Cancer Systems Imaging and Therapy , 2014, BioMed research international.

[28]  U. Knigge,et al.  PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. , 2014, Future oncology.

[29]  M. Fujiki,et al.  Comparison of Multiple Parameters Obtained on 3T Pulsed Arterial Spin-Labeling, Diffusion Tensor Imaging, and MRS and the Ki-67 Labeling Index in Evaluating Glioma Grading , 2014, American Journal of Neuroradiology.

[30]  Subha Madhavan,et al.  NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures , 2014, Translational oncology.

[31]  M. Wakoh,et al.  Comparison of accuracy of intravoxel incoherent motion and apparent diffusion coefficient techniques for predicting malignancy of head and neck tumors using half-Fourier single-shot turbo spin-echo diffusion-weighted imaging. , 2014, Magnetic resonance imaging.

[32]  S. Mittal,et al.  Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors , 2014, Molecular imaging.

[33]  H. Saji,et al.  In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe , 2014, Cancer science.

[34]  Andre Dekker,et al.  Radiogenomics: radiobiology enters the era of big data and team science. , 2014, International journal of radiation oncology, biology, physics.

[35]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[36]  Xuehuan Liu,et al.  The Diagnostic Value of Cervical Lymph Node Metastasis in Head and Neck Squamous Carcinoma by Using Diffusion-Weighted Magnetic Resonance Imaging and Computed Tomography Perfusion , 2014, BioMed research international.

[37]  B. K. Park,et al.  Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI. , 2014, AJR. American journal of roentgenology.

[38]  B. Bender,et al.  Prognostic Value of Blood Flow Measurements Using Arterial Spin Labeling in Gliomas , 2014, PloS one.

[39]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[40]  B. Sirohi,et al.  Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  F. Bowman,et al.  Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. , 2014, The Journal of urology.

[42]  B. K. Park,et al.  Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience , 2014, European Radiology.

[43]  Zhen Cheng,et al.  PET probes beyond 18F-FDG , 2014, Journal of biomedical research.

[44]  Y. Li,et al.  Ultrasound Targeted Apoptosis Imaging in Monitoring Early Tumor Response of Trastuzumab in a Murine Tumor Xenograft Model of Her-2–Positive Breast Cancer1 , 2014, Translational oncology.

[45]  Matthew J. Oborski,et al.  First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy , 2014, Brain and behavior.

[46]  Nirbhay N. Yadav,et al.  Human protamine-1 as an MRI reporter gene based on chemical exchange. , 2014, ACS chemical biology.

[47]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[48]  M. Soussan,et al.  Optimized multimodal nanoplatforms for targeting α(v)β3 integrins. , 2013, Nanoscale.

[49]  T. Holland-Letz,et al.  Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  K. Miles,et al.  Predicting tumour response , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[51]  R. Mach,et al.  Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [18F]ISO-1 , 2013, PloS one.

[52]  V. Pant,et al.  The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity , 2013, Genes & development.

[53]  Giampaolo Tomasi,et al.  18F-ICMT-11, a Caspase-3–Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry , 2013, The Journal of Nuclear Medicine.

[54]  S. Basu,et al.  Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[55]  Ravinder Reddy,et al.  Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications , 2013, Current Radiology Reports.

[56]  P. Coletta,et al.  Non‐invasive molecular imaging for preclinical cancer therapeutic development , 2013, British journal of pharmacology.

[57]  M. Emmert-Buck,et al.  Measuring collective cell movement and extracellular matrix interactions using magnetic resonance imaging , 2013, Scientific Reports.

[58]  Baohong Yuan,et al.  Tumor functional and molecular imaging utilizing ultrasound and ultrasound-mediated optical techniques. , 2013, The American journal of pathology.

[59]  V. Goh,et al.  CT perfusion in oncologic imaging: a useful tool? , 2013, AJR. American journal of roentgenology.

[60]  Mark F. Lythgoe,et al.  In vivo imaging of glucose uptake and metabolism in tumors , 2012, Nature Medicine.

[61]  M. Allard,et al.  (68)Ga-labeled bombesin analogs for receptor-mediated imaging. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[62]  Jin Xie,et al.  Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging. , 2013, Methods in molecular biology.

[63]  C. Bremer,et al.  Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe. , 2013, Contrast media & molecular imaging.

[64]  P. Marsden,et al.  Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. , 2012, European journal of cancer.

[65]  N. Kawai,et al.  Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas , 2012, The Journal of Nuclear Medicine.

[66]  Yoshinori Kato,et al.  Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer , 2012, Magnetic resonance in medicine.

[67]  Kenneth Hoyt,et al.  Volumetric Contrast‐Enhanced Ultrasound Imaging to Assess Early Response to Apoptosis‐Inducing Anti–Death Receptor 5 Antibody Therapy in a Breast Cancer Animal Model , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[68]  John L. Humm,et al.  PET of Hypoxia: Current and Future Perspectives , 2012, The Journal of Nuclear Medicine.

[69]  D. Schuster,et al.  Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents , 2012, Medicinal research reviews.

[70]  B. Bobek-Billewicz,et al.  Squamous cell cancer of hypopharynx and larynx - evaluation of metastatic nodal disease based on computed tomography perfusion studies. , 2012, European journal of radiology.

[71]  F. Gilbert,et al.  Standardising measurement of tumour vascularity by imaging: recommendations for ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography , 2012, European Radiology.

[72]  K. Aoki,et al.  Stable expression of FRET biosensors: A new light in cancer research , 2012, Cancer science.

[73]  E. Rofstad,et al.  Dynamic contrast‐enhanced‐MRI of tumor hypoxia , 2012, Magnetic resonance in medicine.

[74]  J. Ricci,et al.  Cancer metabolism: current perspectives and future directions , 2012, Cell Death and Disease.

[75]  S. Basu.  The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: emphasis on PET-CT. , 2012, Discovery medicine.

[76]  Paul Kinahan,et al.  Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials , 2012, European Radiology.

[77]  O. Schober,et al.  Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. , 2011, The British journal of radiology.

[78]  D. Piao,et al.  Transrectal Ultrasound-Integrated Spectral Optical Tomography of Hypoxic Progression of a Regressing Tumor in a Canine Prostate , 2011, Technology in cancer research & treatment.

[79]  Z. Bhujwalla,et al.  MRI of metastasis-permissive microenvironments. , 2011, Future oncology.

[80]  U. Haberkorn,et al.  Molecular imaging of tumor metabolism and apoptosis , 2011, Oncogene.

[81]  C. Reutelingsperger,et al.  In Vivo Imaging of Apoptosis in Oncology: An Update , 2011, Molecular imaging.

[82]  Kurt I Anderson,et al.  Imaging molecular dynamics in vivo – from cell biology to animal models , 2011, Journal of Cell Science.

[83]  W. Weber,et al.  Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis , 2011, The Journal of Nuclear Medicine.

[84]  Quing Zhu,et al.  Imaging tumor hypoxia by near-infrared fluorescence tomography. , 2011, Journal of biomedical optics.

[85]  H. Hong,et al.  Imaging gene expression in live cells and tissues. , 2011, Cold Spring Harbor protocols.

[86]  S. Dizdarevic,et al.  Imaging of multidrug resistance in cancer , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[87]  John Kurhanewicz,et al.  Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.

[88]  Xilin Sun,et al.  Tumor Hypoxia Imaging , 2011, Molecular Imaging and Biology.

[89]  P. Cappella,et al.  In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation , 2011, Apoptosis.

[90]  A. Alavi,et al.  A new dimension of FDG-PET interpretation: assessment of tumor biology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[91]  Xiaoyuan Chen,et al.  Apoptosis Imaging: Beyond Annexin V , 2010, The Journal of Nuclear Medicine.

[92]  Shaoying Lu,et al.  Fluorescence Resonance Energy Transfer Biosensors for Cancer Detection and Evaluation of Drug Efficacy , 2010, Clinical Cancer Research.

[93]  Takeshi Kondo,et al.  A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells , 2010, Clinical Cancer Research.

[94]  S S Gambhir,et al.  Molecular imaging: current status and emerging strategies. , 2010, Clinical radiology.

[95]  J. Willmann,et al.  Molecular ultrasound imaging: current status and future directions. , 2010, Clinical radiology.

[96]  P Peschke,et al.  Multimodality imaging of hypoxia in preclinical settings. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[97]  S. Laurent,et al.  Superparamagnetic Iron Oxide Nanoparticles , 2017 .

[98]  Sanjiv S. Gambhir,et al.  Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides , 2010, Journal of Nuclear Medicine.

[99]  C. Craik,et al.  Tumor detection by imaging proteolytic activity. , 2010, Cancer research.

[100]  B D Ross,et al.  Hyperpolarized MR Imaging: Neurologic Applications of Hyperpolarized Metabolism , 2010, American Journal of Neuroradiology.

[101]  Erin M. Goldblatt,et al.  From bench to bedside: the growing use of translational research in cancer medicine. , 2010, American journal of translational research.

[102]  E. D. de Vries,et al.  Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets. , 2010, Methods in molecular biology.

[103]  Curzio Rüegg,et al.  Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[104]  A. Pathak,et al.  MR molecular imaging of tumor vasculature and vascular targets. , 2010, Advances in genetics.

[105]  T. Saga,et al.  Molecular MR imaging of cancer gene therapy: ferritin transgene reporter takes the stage. , 2010, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[106]  Melissa C Skala,et al.  Longitudinal optical imaging of tumor metabolism and hemodynamics. , 2010, Journal of biomedical optics.

[107]  Kazunori Kawamura,et al.  [11C]Gefitinib ([11C]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma , 2010, Molecular Imaging and Biology.

[108]  R. Gobetto,et al.  Hyperpolarized agents for advanced MRI investigations. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[109]  M. Hall,et al.  Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications , 2009, Clinical pharmacology and therapeutics.

[110]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[111]  N. Nitta,et al.  Investigation using an HER‐2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug , 2009, Journal of magnetic resonance imaging : JMRI.

[112]  R. Mach,et al.  Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo. , 2009, Central nervous system agents in medicinal chemistry.

[113]  Yin Zhang,et al.  Molecular Imaging of Proteases in Cancer. , 2009, Cancer growth and metastasis.

[114]  T. Cotter,et al.  Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.

[115]  J O Barentsz,et al.  Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. , 2009, Cancer treatment reviews.

[116]  H. Wester,et al.  Molecular imaging targeting peptide receptors. , 2009, Methods.

[117]  F. Mottaghy,et al.  Molecular imaging of cell death. , 2009, Methods.

[118]  K. Miles,et al.  Cost-Effectiveness of 99mTc-Sestamibi in Predicting Response to Chemotherapy in Patients with Lung Cancer: Systematic Review and Meta-Analysis , 2009, Journal of Nuclear Medicine.

[119]  M. Lepage,et al.  New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging. , 2009, Journal of medicinal chemistry.

[120]  P. Price,et al.  Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue , 2009, Molecular Cancer Therapeutics.

[121]  S. Basu,et al.  FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor , 2008, Nuclear medicine communications.

[122]  Assaf A Gilad,et al.  MRI Reporter Genes , 2008, Journal of Nuclear Medicine.

[123]  B. Hamm,et al.  Protease-specific nanosensors for magnetic resonance imaging. , 2008, Bioconjugate chemistry.

[124]  M. Lepage,et al.  Novel solubility‐switchable MRI agent allows the noninvasive detection of matrix metalloproteinase‐2 activity in vivo in a mouse model , 2008, Magnetic resonance in medicine.

[125]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[126]  J. Tait.  Imaging of Apoptosis , 2008, Journal of Nuclear Medicine.

[127]  F. Blankenberg,et al.  Monitoring of treatment-induced apoptosis in oncology with PET and SPECT. , 2008, Current pharmaceutical design.

[128]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[129]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[130]  L. Fass.  Imaging and cancer: A review , 2008, Molecular oncology.

[131]  M. Goodman,et al.  Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography , 2008, Cancer and Metastasis Reviews.

[132]  W. Weber,et al.  Imaging of tumor glucose utilization with positron emission tomography , 2008, Cancer and Metastasis Reviews.

[133]  Markus Schwaiger,et al.  Imaging of integrin αvβ3 expression , 2008, Cancer and Metastasis Reviews.

[134]  June-Key Chung,et al.  Molecular-Genetic Imaging Based on Reporter Gene Expression , 2008, Journal of Nuclear Medicine.

[135]  Kenneth A Krohn,et al.  Molecular Imaging of Hypoxia , 2008, Journal of Nuclear Medicine.

[136]  F. Blankenberg,et al.  In Vivo Detection of Apoptosis , 2008, Journal of Nuclear Medicine.

[137]  David A Mankoff,et al.  Tumor Receptor Imaging , 2008, Journal of Nuclear Medicine.

[138]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[139]  J. Bading,et al.  Imaging of Cell Proliferation: Status and Prospects , 2008, Journal of Nuclear Medicine.

[140]  W. Weber,et al.  Tumor Cell Metabolism Imaging , 2008, Journal of Nuclear Medicine.

[141]  L. Matrisian,et al.  Imaging matrix metalloproteinases in cancer , 2008, Cancer and Metastasis Reviews.

[142]  Cong Li,et al.  Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging. , 2008, Neoplasia.

[143]  W. Fang,et al.  Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study. , 2008, Nuclear medicine and biology.

[144]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[145]  Antony K Chen,et al.  In vivo imaging of cancer biomarkers using activatable molecular probes. , 2008, Cancer biomarkers : section A of Disease markers.

[146]  S. Gambhir,et al.  Chapter 7. Molecular imaging of tumor vasculature. , 2008, Methods in enzymology.

[147]  J. Gore,et al.  Noninvasive Detection of Matrix Metalloproteinase Activity In Vivo using a Novel Magnetic Resonance Imaging Contrast Agent with a Solubility Switch , 2007, Molecular imaging.

[148]  Sanjiv S. Gambhir,et al.  Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.

[149]  M. Rots,et al.  Nuclear imaging of hormonal receptor status in breast cancer: a tool for guiding endocrine treatment and drug development. , 2007, Current cancer drug targets.

[150]  H. Hollema,et al.  In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft , 2007, Journal of Nuclear Medicine.

[151]  A. Pathak,et al.  Molecular-functional imaging of cancer: to image and imagine. , 2007, Trends in molecular medicine.

[152]  Weibo Cai,et al.  Are quantum dots ready for in vivo imaging in human subjects? , 2007, Nanoscale research letters.

[153]  Y. Nishiyama,et al.  Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[154]  W. Heiss,et al.  Multitracer Positron Emission Tomographic Imaging of Exogenous Gene Expression Mediated by a Universal Herpes Simplex Virus 1 Amplicon Vector , 2007, Molecular imaging.

[155]  J. Bulte,et al.  Developing MR reporter genes: promises and pitfalls , 2007, NMR in biomedicine.

[156]  R. Tsien,et al.  Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. , 2007, Cancer research.

[157]  Wolfhard Semmler,et al.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. , 2007, Cancer research.

[158]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[159]  Lihong V. Wang,et al.  In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. , 2007, International journal of oncology.

[160]  A. Koong,et al.  Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[161]  J. Drevs,et al.  The use of vascular biomarkers and imaging studies in the early clinical development of anti‐tumour agents targeting angiogenesis , 2006, Journal of internal medicine.

[162]  Sanjiv S Gambhir,et al.  PET of vascular endothelial growth factor receptor expression. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[163]  W. Cai,et al.  In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3 , 2006 .

[164]  Mauricio Castillo,et al.  Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. , 2006, The Lancet. Oncology.

[165]  John Humm,et al.  Tumor Hypoxia Imaging , 2006, Clinical Cancer Research.

[166]  N. deSouza,et al.  Diffusion-weighted magnetic resonance imaging and its application to cancer , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.

[167]  Dai Fukumura,et al.  Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. , 2006, Cancer research.

[168]  Alnawaz Rehemtulla,et al.  Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. , 2006, Cancer research.

[169]  Shuang Liu.  Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging , 2006 .

[170]  Wafik S El-Deiry,et al.  Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[171]  Horst Kessler,et al.  Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man , 2006, Clinical Cancer Research.

[172]  Robert C Brasch,et al.  Imaging of tumor angiogenesis: current approaches and future prospects. , 2006, Current pharmaceutical design.

[173]  Roland Haubner,et al.  αvβ3-integrin imaging: a new approach to characterise angiogenesis? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[174]  Klaas Nicolay,et al.  Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. , 2006, Bioconjugate chemistry.

[175]  R. Weissleder,et al.  Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. , 2006, Bioconjugate chemistry.

[176]  R. Weissleder.  Molecular Imaging in Cancer , 2006, Science.

[177]  M. Neeman,et al.  Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype. , 2006, Cancer research.

[178]  S. Osman,et al.  Carbogen and Nicotinamide Increase Blood Flow and 5-Fluorouracil Delivery but not 5-Fluorouracil Retention in Colorectal Cancer Metastases in Patients , 2006, Clinical Cancer Research.

[179]  C. Lilley,et al.  A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging , 2006, Cell.

[180]  R. Mason,et al.  Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane , 2006, Magnetic resonance in medicine.

[181]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[182]  Geng Ku,et al.  Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. , 2006, Journal of biomedical optics.

[183]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[184]  S. Achilefu,et al.  In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. , 2006, Nuclear medicine and biology.

[185]  W. Steers,et al.  In vivo detection of apoptotic cells in the testis using fluorescence labeled annexin V in a mouse model of testicular torsion. , 2005, The Journal of urology.

[186]  S. Gambhir,et al.  Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2 , 2006 .

[187]  W. Cai,et al.  Multimodality tumor imaging targeting integrin alphavbeta3. , 2005, BioTechniques.

[188]  M. Neeman,et al.  Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma. , 2005, Cancer research.

[189]  R. Shohet,et al.  Targeting vascular endothelium with avidin microbubbles. , 2005, Ultrasound in medicine & biology.

[190]  R. Weissleder,et al.  Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model. , 2005, Neoplasia.

[191]  K. Claffey,et al.  Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature , 2005, Molecular Cancer Therapeutics.

[192]  J W Hunt,et al.  Monitoring structural changes in cells with high-frequency ultrasound signal statistics. , 2005, Ultrasound in medicine & biology.

[193]  W. El-Deiry,et al.  Bioluminescent imaging of TRAIL-induced apoptosis through detection of caspase activation following cleavage of DEVD-aminoluciferin , 2005, Cancer Biology & Therapy.

[194]  Catherine M Shachaf,et al.  Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy. , 2005, Cancer research.

[195]  M. Pomper,et al.  Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer , 2005, Clinical Cancer Research.

[196]  T. McMurry,et al.  Gadolinium meets medicinal chemistry: MRI contrast agent development. , 2005, Current medicinal chemistry.

[197]  J. Bading,et al.  Integrin αβ3-Targeted Imaging of Lung Cancer , 2005 .

[198]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[199]  Horst Kessler,et al.  Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD , 2005, PLoS medicine.

[200]  C. Dence,et al.  Positron tomographic assessment of androgen receptors in prostatic carcinoma , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[201]  M. Dewhirst,et al.  Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity. , 2005, Cancer research.

[202]  R. Tsien.  Building and breeding molecules to spy on cells and tumors , 2005, FEBS letters.

[203]  James H Thrall,et al.  Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.

[204]  D. Piwnica-Worms,et al.  Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[205]  R. Reilly,et al.  Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments. , 2005, Nuclear medicine and biology.

[206]  Kenneth A Krohn,et al.  Imaging hypoxia and angiogenesis in tumors. , 2005, Radiologic clinics of North America.

[207]  P. Kinnunen,et al.  Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide. , 2005, Anticancer research.

[208]  R. Tsien,et al.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.

[209]  R. Brasch,et al.  MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer , 2004, Journal of magnetic resonance imaging : JMRI.

[210]  Christopher H. Contag,et al.  MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.

[211]  Peter S. Conti,et al.  Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression , 2004 .

[212]  C. Wiele,et al.  Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status , 2004 .

[213]  F. Hoebers,et al.  In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[214]  W. Schima,et al.  Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[215]  Ryan Park,et al.  microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[216]  N. Lemoine,et al.  Noninvasive Imaging of the Transcriptional Activities of Human Telomerase Promoter Fragments in Mice , 2004, Cancer Research.

[217]  R. Kalluri,et al.  The contribution of vascular basement membranes and extracellular matrix to the mechanics of tumor angiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[218]  Neal Rosen,et al.  Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors , 2004, Nature Biotechnology.

[219]  M. Vannan,et al.  Targeted ultrasound imaging using microbubbles. , 2004, Cardiology clinics.

[220]  M. Schwaiger,et al.  Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. , 2004, Nuclear medicine and biology.

[221]  F Forsberg,et al.  Assessment of angiogenesis: implications for ultrasound imaging. , 2004, Ultrasonics.

[222]  Y. Erdi,et al.  Tumor Localization of 16β-18F-Fluoro-5α-Dihydrotestosterone Versus 18F-FDG in Patients with Progressive, Metastatic Prostate Cancer , 2004 .

[223]  D. Lee,et al.  Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[224]  B. Ruggeri,et al.  Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy. , 2004, Current medicinal chemistry.

[225]  R. Tsien,et al.  Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects , 2004, Cancer Research.

[226]  N. Saijo,et al.  Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (“Iressa”) and the DNA topoisomerase I inhibitor CPT‐11 (irinotecan) in human colorectal cancer cells , 2004, International journal of cancer.

[227]  Dawen Zhao,et al.  Measuring changes in tumor oxygenation. , 2004, Methods in enzymology.

[228]  H. Herschman.  Noninvasive imaging of reporter gene expression in living subjects. , 2004, Advances in cancer research.

[229]  O. Muzik,et al.  Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[230]  Peter S. Conti,et al.  MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[231]  L. Matrisian,et al.  Molecular imaging of proteolytic activity in cancer , 2003, Journal of cellular biochemistry.

[232]  R. Blasberg.  In vivo molecular-genetic imaging: multi-modality nuclear and optical combinations. , 2003, Nuclear medicine and biology.

[233]  P. C. Lin,et al.  Optical imaging and tumor angiogenesis , 2003, Journal of cellular biochemistry.

[234]  Jongho Lee,et al.  Functional brain imaging using a blood oxygenation sensitive steady state , 2003, Magnetic resonance in medicine.

[235]  Lien Wp,et al.  Imaging matrix metalloproteinase expression in tumors. , 2003 .

[236]  J. Yap,et al.  Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[237]  Scott E Fraser,et al.  The year(s) of the contrast agent - micro-MRI in the new millennium. , 2003, Current opinion in immunology.

[238]  P. Angelberger,et al.  Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[239]  R. Mason,et al.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. , 2003, Neoplasia.

[240]  M. Bock,et al.  High‐resolution three‐dimensional MR angiography of rodent tumors: Morphologic characterization of intratumoral vasculature , 2003, Journal of magnetic resonance imaging : JMRI.

[241]  L. Mortelmans,et al.  Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[242]  R. Kalluri.  Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[243]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[244]  Dmitri Artemov,et al.  Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.

[245]  M. Brauer.  In vivo monitoring of apoptosis , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[246]  S. Libutti,et al.  Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[247]  Hisataka Kobayashi,et al.  Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. , 2003, Cancer research.

[248]  Bernard Gallez,et al.  How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? , 2002, Magnetic resonance in medicine.

[249]  Milind Rajopadhye,et al.  Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. , 2002, Cancer research.

[250]  Roy Bicknell,et al.  The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. , 2002, Cancer research.

[251]  Jamal Zweit,et al.  Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. , 2002, Journal of the National Cancer Institute.

[252]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[253]  Yong A. Yu,et al.  Renilla luciferase-Aequorea GFP (Ruc-GFP) fusion protein, a novel dual reporter for real-time imaging of gene expression in cell cultures and in live animals , 2002, Molecular Genetics and Genomics.

[254]  L. Ellis,et al.  Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[255]  Roland Hustinx,et al.  Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[256]  June-Key Chung,et al.  Sodium iodide symporter: its role in nuclear medicine. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[257]  Adam P Dicker,et al.  Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results. , 2002, Ultrasound in medicine & biology.

[258]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[259]  R. Weissleder,et al.  Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. , 2002, Radiology.

[260]  D. Cosgrove,et al.  Advances in ultrasound. , 2002, Clinical radiology.

[261]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[262]  A. Szalay,et al.  Imaging of light emission from the expression of luciferases in living cells and organisms: a review. , 2002, Luminescence : the journal of biological and chemical luminescence.

[263]  C. Zippe,et al.  Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease , 2002, Prostate Cancer and Prostatic Diseases.

[264]  R Weissleder,et al.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.

[265]  R. Williamson,et al.  Synthesis and characterization of 111In-DTPA-N-TIMP-2: a radiopharmaceutical for imaging matrix metalloproteinase expression. , 2001, Bioconjugate chemistry.

[266]  R. Weissleder,et al.  Human transferrin receptor gene as a marker gene for MR imaging. , 2001, Radiology.

[267]  M. Dowsett,et al.  Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. , 2001, Endocrine-related cancer.

[268]  M. O'Doherty,et al.  In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection , 2001, European Journal of Nuclear Medicine.

[269]  A. Bjørnerud,et al.  A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.

[270]  P. Valent,et al.  Characterization of 123I‐vascular endothelial growth factor–binding sites expressed on human tumour cells: Possible implication for tumour scintigraphy , 2001, International journal of cancer.

[271]  Sibylle Ziegler,et al.  Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .

[272]  N. Chaffey.  Red fluorescent protein , 2001 .

[273]  V. Ntziachristos,et al.  Hydrophilic Cyanine Dyes as Contrast Agents for Near-infrared Tumor Imaging: Synthesis, Photophysical Properties and Spectroscopic In vivo Characterization¶ , 2000, Photochemistry and photobiology.

[274]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[275]  S. Osman,et al.  Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action , 2000, The Lancet.

[276]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[277]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[278]  J W Hunt,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0724 Ultrasound imaging of apoptosis: high-resolution noninvasive , 2022 .

[279]  S. Cherry,et al.  Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals , 1999, Gene Therapy.

[280]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[281]  Jonson Sd,et al.  PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins. , 1998 .

[282]  F. Blankenberg,et al.  Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.

[283]  V. Ling.  Multidrug resistance: molecular mechanisms and clinical relevance , 1997, Cancer Chemotherapy and Pharmacology.

[284]  M. Berridge,et al.  The use of 3-methoxymethyl-16β, 17β-epiestriol-O-cyclic sulfone as the precursor in the synthesis of F-18 16α-fluoroestradiol , 1996 .

[285]  F. Blankenberg,et al.  Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. , 1996, Blood.

[286]  R. Blasberg,et al.  Imaging the expression of transfected genes in vivo. , 1995, Cancer research.

[287]  C. Osborne,et al.  Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[288]  M J Welch,et al.  Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.